PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alkermes plc (ALKS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINIE00B56GVS15
CUSIP00B56GVS1
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$4.04B
EPS$3.06
PE Ratio7.79
PEG Ratio-1,057.29
Revenue (TTM)$1.66B
Gross Profit (TTM)$893.69M
EBITDA (TTM)$495.05M
Year Range$22.01 - $33.71
Target Price$35.55
Short %9.79%
Short Ratio6.93

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alkermes plc

Popular comparisons: ALKS vs. VOO, ALKS vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alkermes plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
-1.47%
18.82%
ALKS (Alkermes plc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Alkermes plc had a return of -13.23% year-to-date (YTD) and -18.07% in the last 12 months. Over the past 10 years, Alkermes plc had an annualized return of -6.01%, while the S&P 500 had an annualized return of 10.42%, indicating that Alkermes plc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-13.23%5.05%
1 month-11.80%-4.27%
6 months-1.47%18.82%
1 year-18.07%21.22%
5 years (annualized)-7.10%11.38%
10 years (annualized)-6.01%10.42%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-2.49%9.76%-8.82%
2023-4.04%-13.64%-0.21%14.91%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALKS is 29, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of ALKS is 2929
Alkermes plc(ALKS)
The Sharpe Ratio Rank of ALKS is 2828Sharpe Ratio Rank
The Sortino Ratio Rank of ALKS is 2727Sortino Ratio Rank
The Omega Ratio Rank of ALKS is 2727Omega Ratio Rank
The Calmar Ratio Rank of ALKS is 3737Calmar Ratio Rank
The Martin Ratio Rank of ALKS is 2727Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alkermes plc (ALKS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALKS
Sharpe ratio
The chart of Sharpe ratio for ALKS, currently valued at -0.46, compared to the broader market-2.00-1.000.001.002.003.00-0.46
Sortino ratio
The chart of Sortino ratio for ALKS, currently valued at -0.47, compared to the broader market-4.00-2.000.002.004.00-0.47
Omega ratio
The chart of Omega ratio for ALKS, currently valued at 0.94, compared to the broader market0.501.001.500.94
Calmar ratio
The chart of Calmar ratio for ALKS, currently valued at -0.22, compared to the broader market0.001.002.003.004.005.00-0.22
Martin ratio
The chart of Martin ratio for ALKS, currently valued at -1.01, compared to the broader market0.0010.0020.0030.00-1.01
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.81, compared to the broader market-2.00-1.000.001.002.003.001.81
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.004.002.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.001.002.003.004.005.001.38
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Alkermes plc Sharpe ratio is -0.46. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.46
1.81
ALKS (Alkermes plc)
Benchmark (^GSPC)

Dividends

Dividend History


Alkermes plc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-75.45%
-4.64%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alkermes plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alkermes plc was 96.15%, occurring on Jul 11, 2002. The portfolio has not yet recovered.

The current Alkermes plc drawdown is 75.45%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.15%Mar 2, 2000591Jul 11, 2002
-92.95%Jan 10, 1992755Jan 4, 1995537Feb 18, 19971292
-64.98%Feb 19, 199748Apr 28, 1997440Jan 26, 1999488
-44.58%Nov 4, 199118Nov 27, 199124Jan 3, 199242
-28.52%Mar 22, 199942May 19, 199957Aug 10, 199999

Volatility

Volatility Chart

The current Alkermes plc volatility is 8.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
8.03%
3.30%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alkermes plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items